Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is a publicly traded Healthcare sector company. As of May 21, 2026, HRMY trades at $31.38 with a market cap of $1.73B and a P/E ratio of 12.41. HRMY moved +3.09% today. Year to date, HRMY is -14.61%; over the trailing twelve months it is -11.90%. Its 52-week range spans $25.52 to $41.61. Analyst consensus is buy with an average price target of $43.44. Rallies surfaces HRMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. HRMY moved +3.09% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $31.38 |
| Market Cap | $1.73B |
| P/E Ratio | 12.41 |
| EPS | $2.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.61 |
| 52-Week Low | $25.52 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $899.11M |
| Net Income | $145.62M |
| Gross Margin | 76.55% |
9 analysts cover HRMY: 0 strong buy, 5 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $43.44.